Functional role of wogonin in anti-angiogenesis

American Journal of Chinese Medicine

Volumn 40, Issue 2, 2012, Pages 415-427

  Lin, Chiu Mei ^a,b,c   Chen, Yen Hsu ^d,e   Ong, Jiann Ruey ^a   Ma, Hon Ping ^f   Shyu, Kou Gi ^a,f   Bai, Kuan Jen ^f  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL ILAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; IL 6; JAK1 STAT3; VEGF; Wogonin

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE 1; SMALL INTERFERING RNA; STAT3 PROTEIN; VASCULOTROPIN; WOGONIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANGIOGENESIS INHIBITORS; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FLAVANONES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; JANUS KINASE 1; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863388470     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500322     Document Type: Article

References (30)

1. Aggarwal, B.B., G. Sethi, K.S. Ahn, S.K. Sandur, M.K. Pandey, A.B. Kunnumakkara, B. Sung and H. Ichikawa. Targeting signal-transducer-and- activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann. NY Acad. Sci. 1091: 151-169, 2006. (Pubitemid 47092233)
2. Angelo, L.S. and R. Kurzrock. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin. Cancer Res. 13: 2825-2830, 2007. (Pubitemid 46849555)
3. Bhutani, M., A.K. Pathak, A.S. Nair, A.B. Kunnumakkara, S. Guha and B.B. Aggarwal. Capsaicin is a novel blocker of constitutive and interleukin-6- inducible STAT3 activation. Clin. Cancer Res. 13: 3024-3032, 2007. (Pubitemid 46849579)
4. Cao, Y., R. Cao and E. Brakenhielm. Antiangiogenic mechanisms of diet-derived polyphenols. J. Nutr. Biochem. 13: 380-390, 2002. (Pubitemid 34733007)
5. García-Lafuente, A., E. Guillamón, A. Villares, M.A. Rostagno and J.A. Martínez. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 58: 537-552, 2009.
6. Gomez, D. and N.C. Reich. Stimulation of primary human endothelial cell proliferation by IFN. J. Immunol. 170: 5373-5381, 2003. (Pubitemid 36617822)
7. Heinrich, P.C., I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen and F. Schaper. Principles of interleukin (IL)-6- type cytokine signaling and its regulation. Biochem. J. 374: 1-20, 2003. (Pubitemid 37046923)
8. Hernandez-Rodriguez, J., M. Sergarra, C. Valardell, M. Sanchez, A. Garcia-Martinez and M.C. Cid. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 107: 2428-2434, 2003. (Pubitemid 36605224)
9. Ishii, K., S. Tanaka, K. Kagami, K. Henmi, H. Toyoda, T. Kaise and T. Hirano. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Invest. 28: 220-229, 2010.
10. Jaffe, E.A., R.L. Nachman, C.G. Becker and C.R. Minick. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-2756, 1973.
11. Kaneko, T., H. Chiba, T. Kato, M. Kobayashi, K. Hashimoto, K. Kusama and H. Sakagami. Inhibition of prostaglandin E2 production by flavone and its related compounds. In Vivo 24: 555-558, 2010.
12. Kavsak, P.A., A. Lee, H. Hirte, E. Young and J. Gauldie. Cytokine elevations in acute coronary syndrome and ovarian cancer: a mechanism for the up-regulation of the acute phase proteins in these different disease etiologies. Clin. Biochem. 41: 607-610, 2008.
13. Lin, C.M., H. Chang, Y.H. Chen, I.S. Wu and J.H. Chiu. Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, but not VEGFR-2. Planta Med. 72: 1305-1310, 2006a. (Pubitemid 44862032)
14. Lin, C.M., H. Chang, S.Y. Li, I.S. Wu and J.H. Chiu. Chrysin inhibit lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways. Planta Med. 72: 708-714, 2006b. (Pubitemid 44073454)
15. Lin, C.M., J.H. Chiu, I.H. Wu, B.W. Wang, C.M. Pan and Y.H. Chen. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha. J. Nutr. Biochem. 21: 627-633, 2010a.
16. Lin, C.M., K.G. Shyu, B.W. Wang, H. Chang, Y.H. Chen and J.H. Chiu. Chrysin suppresses IL-6- induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach. J. Agric. Food Chem. 58: 7082-7087, 2010b.
17. Liu, S., Z. Ma, H. Cai, Q. Li, W. Rong and M. Kawano. Inhibitory effect of baicalein on IL-6- mediated signaling cascades in human myeloma cells. Eur. J. Haematol. 84: 137-144, 2010.
18. Li-Weber, M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 35: 57-68, 2009.
19. Nian, M., P. Lee, N. Khaper and P. Liu. Inflammatory cytokines and postmyocardial infarction modeling. Circ. Res. 94: 1543-1553, 2004. (Pubitemid 38856961)
20. Niu, G., K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L.M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove and H. Yu. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008, 2002. (Pubitemid 34270888)
21. Parajuli, P., N. Joshee, A.M. Rimando, S. Mittal and A.K. Yadav. In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med. 75: 41-48, 2009.
22. Rathee, P., H. Chaudhary, S. Rathee, D. Rathee, V. Kumar and K. Kohli. Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm. Allerg. Drug Targets 8: 229-235, 2009.
23. Risau, W. Mechanism of angiogenesis. Nature 386: 671-674, 1997.
24. Salven, P., K. Hattori, B. Heissig and S. Rafii. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16: 1471-1473, 2002.
25. Schoppmann, S.F. Lymphangiogenesis, inflammation and metastasis. Anticancer Res. 25: 4503-4511, 2005.
26. Su, L., K.P. Lai, C.A. Chen, C.Y. Yang, P.S. Chen and L.H. Wei. A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Cancer Res. 65: 4827-4835, 2005.
27. Wang, B.W., H. Chang, S. Lin, P. Kuan and K.G. Shyu. Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells. Cardiovasc. Res. 59: 460-469, 2003. (Pubitemid 37272040)
28. Wecik, E., J. Jakubowicz, P. Skotnicki, B. Sas-Korczynska and J.K. Kulpa. IL-6 and VEGF in small cell lung cancer patients. Anticancer Res. 30: 1773-1778, 2010.
29. Xu, Q., J. Briggs, S. Park, G. Niu, M. Kortylewski, S. Zhang, T. Gritsko, J. Turkson, H. Kay, G.L. Semenza, J.Q. Cheng, R. Jove and H. Yu. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24: 5552-5560, 2005. (Pubitemid 43119350)
30. Zhao, Q., J. Wang, M.J. Zou, R. Hu, L. Zhao, L. Qiang, J.J. Rong, Q.D. You and Q.L. Guo. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism. Toxicol. Lett. 197: 201-210, 2010.